Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Jun
29
2013
Financial Innovation for Clean Energy Deployment: Congress Considers Expanding Master Limited Partnerships for Clean Energy Mintz
Jul
31
2013
Energy and Environment Law Update - July 29, 2013 Mintz
Sep
19
2013
The Massachusetts Clean Energy Center Releases 2013 Clean Technology Industry Report Showing Strong Growth in Massachusetts Mintz
Oct
1
2013
Energy and Environment Law Update - September 30, 2013 Mintz
Oct
12
2021
Coverage of FDA’s AI/ML Medical Devices Workshop - Part 2: FDA’s Recent Digital Health Initiatives Mintz
Oct
21
2013
Energy and Environmental Law Update - October 21, 2013 Mintz
Nov
13
2013
Energy and Environmental Law Update - November 11, 2013 Mintz
Dec
19
2013
Senate Finance Committee Proposes Overhaul of Clean Energy Tax Provisions Mintz
Oct
29
2018
Trump Administration Proposes to Lower Drug Prices Through Medicare Part B Mintz
Dec
19
2018
Observations from FDA’s Public Workshop on Medical Device Servicing and Remanufacturing Mintz
Apr
1
2014
Energy and Environmental Law Update - March 31, 2014 Mintz
Jan
25
2022
OIG Approves Online Retailer’s Discount Program Mintz
Feb
11
2019
Federal Circuit Dismisses Appeal of IPR Final Written Decision for Lack of Standing After Appellant Terminated Development of Potentially Infringing Pharmaceutical Product Mintz
Feb
21
2019
CMS Continues to Combat the Opioid Epidemic Mintz
Jul
31
2014
Energy Technology Connections - July 2014 Mintz
Sep
12
2014
National Institute of Standards and Technology (NIST) Issues Draft Report Enumerating Risks and Protections to Consider When Evaluating Mobile Apps for Your Enterprise Mintz
Oct
17
2014
Front End Changes and, Again, More Direct and Indirect Remuneration (DIR) Columns Mintz
Apr
29
2019
MLS Weekly Preview: Medicare For All Gets a Hearing Mintz
Jun
22
2022
EPA follows the first rule of holes in its eighth attempt to determine the reach of the Clean Water Act Mintz
Dec
23
2014
Health Care Law Update - December 22, 2014 Mintz
Jan
16
2015
FDA Proposes to Apply Risk-Based Framework to Accessory Devices Mintz
Aug
10
2022
Senate Democrats Pass Long-Awaited Drug Pricing Reforms in Budget Reconciliation Bill Mintz
Mar
11
2015
What to Make of a Diminished Thing: Tobacco Bond Defaults and Restructurings Mintz
Apr
9
2015
CMS Takes Initial Steps to Address Medicare & Medicaid Coverage for Biosimilars Mintz
Oct
3
2022
Living the High Life: Separation of Work and Home? Mintz
May
1
2015
Petitioners Must Present Sufficient Evidence to Establish Inherency Mintz
Jun
9
2015
State Action May Block Big Savings on Biosimilars Mintz
Jun
26
2015
FDA Reports Results of Annual Crack Down on Illegal Internet Pharmacies Mintz
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins